Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Palliative Treatments in Advanced HCC
NCT01409499Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2011
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Started Jan 2011; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01409499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01409499.